Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/12/2012US20120177729 Sustained release composition of ranolazine
07/12/2012US20120177728 Oxaliplatin nanoparticles and method for preparing same
07/12/2012US20120177726 Medical use of spla2 hydrolysable liposomes
07/12/2012US20120177725 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
07/12/2012US20120177723 SiRNA PHOSPHOLIPID CONJUGATE
07/12/2012US20120177722 Lyaseenzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177717 Sustained drug delivery system
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177712 antimicrobial particle and a process for preparing the same
07/12/2012US20120177706 Stable combinations of amlodipine besylate and benazepril hydrochloride
07/12/2012US20120177705 Composition 064
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177698 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
07/12/2012US20120177696 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
07/12/2012US20120177693 Deep lung pulmonary delivery of treprostinil
07/12/2012US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
07/12/2012US20120177691 Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
07/12/2012US20120177690 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/12/2012US20120177681 Formulation of immunopotentiators
07/12/2012US20120177656 Compounds and Methods for the Modulation of Sulfilimine Bond Formation
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177641 Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
07/12/2012US20120177634 Demethylpenclomedine analogs and their use as anti-cancer agents
07/12/2012US20120177632 Methods of optimizing disease treatment
07/12/2012US20120177626 Hdl comprising a therapeutic agent and use in therapy
07/12/2012US20120177623 Compositions for Boosting Metabolism, Assisting Weight Loss, and Promoting Cardiovascular Health
07/12/2012US20120177620 Probiotic, Lactic Acid-Producing Bacteria
07/12/2012US20120177602 Dissolution aids for oral peptide delivery comprising a biguanide
07/12/2012US20120177601 Treatment of hepatitis c virus infections
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177599 Compositions and methods for treatment, diagnosis and prognonis of mesothelioma
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177594 Polyion complex comprising phd2 expression inhibiting substance
07/12/2012US20120177593 Synthesis of dendrimer conjugates
07/12/2012US20120177591 Co-Therapy for Diabetic Conditions
07/12/2012US20120177590 Soft anticholinergic esters
07/12/2012US20120177585 Compositions and methods for treating purpura
07/12/2012US20120177583 Compositions for anorectal use and methods for treating anorectal disorders
07/12/2012US20120177582 Compositions for anorectal use and methods for treating anorectal disorders
07/12/2012US20120177573 Methods for conjugating nucleic acids with small molecules
07/12/2012US20120177570 Trpv1 antagonists including amide substituent and uses thereof
07/12/2012DE102011105594A1 Mixture useful as a medicament and/or for producing a medicament, preferably infusion- or drinking solution, comprises ribose, alanine and glycine
07/12/2012DE102011008352A1 5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate 5 - ([1,2,3] triazol-4-yl) -7H-pyrrolo [2,3-d] pyrimidine derivatives
07/12/2012DE102011008070A1 Use of tocotrienol for prevention, aftercare, treatment or auxiliary treatment of proliferative diseases, inflammatory diseases, heart disease, diseases of nervous system, and aftercare of surgical interventions or mitigation of swelling
07/12/2012DE102011000048A1 Mittel zur topischen Behandlung von Hauterkrankungen Agents for topical treatment of skin diseases
07/12/2012CA2834968A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
07/12/2012CA2834101A1 Novel indole or indazole derivative or salt thereof
07/12/2012CA2825989A1 Anti-cancer regimen
07/12/2012CA2824028A1 Novel ureas for the treatment and prevention of cancer
07/12/2012CA2824013A1 Novel bicyclic compound or salt thereof
07/12/2012CA2823969A1 2,4-diamino-6,7-dihydro-5h-pyrrolo[2,3]pyrimidine derivatives as fak/pyk2 inhibitors
07/12/2012CA2823949A1 Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer
07/12/2012CA2823935A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012CA2823908A1 Method for selecting patient to be given drug for treating septicemia
07/12/2012CA2823891A1 Milk yield and/or milk quality improving agent, perinatal disease preventive or therapeutic agent, and reproductivity improving agent for ruminant
07/12/2012CA2823848A1 Nicotinic receptor non-competitive antagonists
07/12/2012CA2823753A1 Heterocyclic compounds for the inhibition of pask
07/12/2012CA2823747A1 Liposome formulation suitable for treating or preventing tuberculosis
07/12/2012CA2823736A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/12/2012CA2823665A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
07/12/2012CA2823616A1 Immunosuppressant formulations
07/12/2012CA2823397A1 Chemosensory receptor ligand-based therapies
07/12/2012CA2822907A1 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
07/12/2012CA2822777A1 Fused aminodihydrothiazine derivatives
07/12/2012CA2822683A1 Bepotastine compositions
07/12/2012CA2822300A1 Compositions and methods of aloe polysaccharides
07/12/2012CA2821640A1 Pyrrolidine derivatives as nk3 antagonists
07/12/2012CA2821524A1 Combination steroid and glucocorticoid receptor antagonist therapy
07/12/2012CA2819234A1 Pharmaceutical compositions of iron for oral administration
07/11/2012EP2474617A1 Mir for treating neo-angiogenesis
07/11/2012EP2474569A1 Porous structure
07/11/2012EP2474552A1 New saccharide mimics and their use as inhibitors of angiogenesis and metastasis formation
07/11/2012EP2474550A1 Derivatives of Englerin for the treatment of cancer
07/11/2012EP2474549A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type I inhibitors
07/11/2012EP2474547A2 Process for the Synthesis of Moxifloxacin Hydrochloride
07/11/2012EP2474546A1 Thiophene-carboxamides useful as inhibitors of protein kinases
07/11/2012EP2474545A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
07/11/2012EP2474544A1 Therapeutic agent for anxiety disorders
07/11/2012EP2474543A1 Therapeutic agent for mood disorders
07/11/2012EP2474541A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
07/11/2012EP2474540A1 Gpr119 agonist
07/11/2012EP2474534A1 3-Aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
07/11/2012EP2474533A1 1-(substituted benzyl)-5-trifluoromethyl-2-(1h) pyridone compounds and their salts, their preparation methods and use thereof
07/11/2012EP2474531A2 Matrix metalloproteinase inhibitors
07/11/2012EP2474530A1 Indole derivative and pharmacologically acceptable salt thereof
07/11/2012EP2474529A1 Crystalline forms of an active pharmaceutical ingredient
07/11/2012EP2474522A1 Agomelatine and pharmaceutical compositions thereof
07/11/2012EP2474521A1 High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them
07/11/2012EP2474328A2 Mechanism-based targeted pancreatic beta cell imaging and therapy
07/11/2012EP2474325A1 Drug composition for angiogenesis therapy
07/11/2012EP2474323A2 Imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
07/11/2012EP2474317A1 Treatment of conditions involving demyelination
07/11/2012EP2474314A1 Antiphlogistic, antioncotic and analgesic chinese herbal composition preparative method and usage thereof
07/11/2012EP2474313A1 Novel self-assembling polyphenol-quinonoid polymer derivatives and use thereof
07/11/2012EP2474312A1 Means for topical treatment of skin ailments
07/11/2012EP2474311A2 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
07/11/2012EP2474310A1 Method for producing polymerized coordination compounds of platinum complex
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 7860